Showing results (451-460 of 470) with videos related to

Sort By:
Pageof 47
Journal of Translational Medicine|May 3, 2013
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α productionStefania Laurent, Paola Queirolo, Silvia Boero, et al.
BMB Reports|October 25, 2014
Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivoHyuk Soon Kim, Jun Ho Lee, Hee Dong Han, et al.
Bioengineered|August 11, 2020
Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?Xun Lai, Yun Yan Sun, Lung Ji Chang, et al.
CNS Neuroscience & Therapeutics|February 9, 2024
S-9-PAHSA's neuroprotective effect mediated by CAIII suppresses apoptosis and oxidative stress in a mouse model of type 2 diabetesJian-Tao Wang, Xin-Ru Wang, Jiao-Qi Ren, et al.
BMC Public Health|May 10, 2013
Burden of self-reported acute gastrointestinal illness in China: a population-based surveyYan Chen, Wei-Xing Yan, Yi-Jing Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2009
Regulation of adult hematopoietic stem cells fate for enhanced tissue-specific repairNilanjana Sengupta, Sergio Caballero, Sean M Sullivan, et al.
Frontiers in Molecular Neuroscience|August 27, 2025
S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulationXin-Ru Wang, Shan-Shan Huang, Meng Wang, et al.
Frontiers in Immunology|December 17, 2020
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin LymphomasXuan Zhou, Sanfang Tu, Chunsheng Wang, et al.
Frontiers in Molecular Neuroscience|September 25, 2025
Correction: S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulationXin-Ru Wang, Shan-Shan Huang, Meng Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 8, 2013
[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma]Ding-zhi Huang, Jian-ping Xiong, Nong Xu, et al.
Pageof 47